(CLN) Clariant - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0012142631
CLN: Specialty Chemicals, Catalysts, Adsorbents, Additives
Clariant AG is a global leader in the specialty chemicals sector, with a rich history dating back to 1886. Headquartered in Muttenz, Switzerland, the company operates across three main segments: Care Chemicals, Catalysis, and Adsorbents & Additives. Each segment is tailored to meet specific industrial needs, positioning Clariant as a key player in various markets.
The Care Chemicals division specializes in creating innovative solutions for industries such as automotive, construction, healthcare, and personal care. For instance, their additives for automotive fluids enhance performance and durability, while their personal care products cater to the cosmetic industry with advanced ingredients that improve skin care formulations.
The Catalysis segment is at the forefront of sustainable technologies, offering catalysts for cleaner energy production. Clariants catalysts are used in hydrogen production, methanol synthesis, and biofuels, supporting the transition to low-carbon energy sources. Their focus on R&D in this area underscores their commitment to environmental sustainability.
The Adsorbents & Additives segment provides critical solutions for industries like oil, gas, and mining. Their products range from refinery additives to wastewater treatment chemicals, ensuring efficiency and safety. This segment also addresses emerging needs, such as chemical recycling and renewable fuel purification, aligning with global sustainability goals.
Clariants strategic position in the specialty chemicals market is bolstered by its extensive global reach and commitment to innovation. Investors may note the companys market cap of 3660.08M CHF and forward P/E of 10.76, indicating potential growth. Ticker symbol CLN on the Swiss exchange reflects its stability and market presence.
Additional Sources for CLN Stock
CLN Stock Overview
| Market Cap in USD | 3,369m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Specialty Chemicals |
| IPO / Inception |
CLN Stock Ratings
| Growth Rating | -62.9 |
| Fundamental | 21.1 |
| Dividend Rating | 7.82 |
| Rel. Strength | -27.6 |
| Analysts | - |
| Fair Price Momentum | 7.51 CHF |
| Fair Price DCF | 17.61 CHF |
CLN Dividends
| Dividend Yield 12m | 4.01% |
| Yield on Cost 5y | 3.13% |
| Annual Growth 5y | -31.30% |
| Payout Consistency | 70.9% |
CLN Growth Ratios
| Growth Correlation 3m | -60.7% |
| Growth Correlation 12m | -90.5% |
| Growth Correlation 5y | -73.4% |
| CAGR 5y | -8.17% |
| CAGR/Max DD 5y | -0.14 |
| Sharpe Ratio 12m | -0.87 |
| Alpha | -38.86 |
| Beta | 0.762 |
| Volatility | 44.08% |
| Current Volume | 1178.7k |
| Average Volume 20d | 1414.4k |
As of April 24, 2025, the stock is trading at CHF 8.76 with a total of 1,178,720 shares traded.
Over the past week, the price has changed by +3.55%, over one month by -14.37%, over three months by -12.09% and over the past year by -31.84%.
Neither. Based on ValueRay Fundamental Analyses, Clariant is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 21.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLN as of April 2025 is 7.51. This means that CLN is currently overvalued and has a potential downside of -14.27%.
Clariant has no consensus analysts rating.
According to ValueRays Forecast Model, CLN Clariant will be worth about 8.1 in April 2026. The stock is currently trading at 8.76. This means that the stock has a potential downside of -7.31%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 12.3 | 40.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 8.1 | -7.3% |